US FDA has approved Tekamlo (aliskiren and amlodipine) tablets for hypertension

US FDA approved the use of Tekamlo (aliskiren/amlodipine) 150 mg/5 mg, 150 mg/10 mg, 300 mg/5 mg and 300 mg/10 mg Tablets for treatment of hypertension as initial therapy in patients likely to need multiple drugs to achieve their blood pressure goals and in patients not adequately controlled with monotherapy.
Tekamlo is a combination of aliskiren, a renin inhibitor, and amlodipine, a dihydropyridine calcium channel blocker, indicated for the treatment of hypertension.

http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022545s000lbl.pdf
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022184s000ltr.pdf